Phillip Dinh

2.2k total citations
33 papers, 1.1k citations indexed

About

Phillip Dinh is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Phillip Dinh has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 21 papers in Hepatology and 4 papers in Infectious Diseases. Recurrent topics in Phillip Dinh's work include Hepatitis B Virus Studies (23 papers), Hepatitis C virus research (21 papers) and Liver Disease Diagnosis and Treatment (14 papers). Phillip Dinh is often cited by papers focused on Hepatitis B Virus Studies (23 papers), Hepatitis C virus research (21 papers) and Liver Disease Diagnosis and Treatment (14 papers). Phillip Dinh collaborates with scholars based in United States, France and Canada. Phillip Dinh's co-authors include Patrick Marcellin, John F. Flaherty, Eduardo B. Martins, Leland J. Yee, Marı́a Buti, Scott Fung, Thomas Berg, Selım Gürel, Rohit Loomba and John G. McHutchison and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Phillip Dinh

32 papers receiving 1.1k citations

Peers

Phillip Dinh

EPIDE

HEPAT

SURGE

PFM

S. Zaltron Italy

Sergio Rodríguez‐Tajes Spain

Mauro Annese Italy

Faleh Z. Al-Faleh Saudi Arabia

Stefan Bourgeois Belgium

P. Wantzin Denmark

Sergio Rojter United States

Paola Piccolo Italy

M Chousterman France

Gökhan Kabaçam Türkiye

S. Zaltron Italy

Phillip Dinh

728 ×0.7

EPIDE

777 ×0.8

HEPAT

325 ×2.1

24 ×0.6

SURGE

14 ×0.5

PFM

Citations per year, relative to Phillip Dinh Phillip Dinh (= 1×) peers S. Zaltron

Countries citing papers authored by Phillip Dinh

Since Specialization

Citations

This map shows the geographic impact of Phillip Dinh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Dinh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Dinh more than expected).

Fields of papers citing papers by Phillip Dinh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip Dinh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Dinh. The network helps show where Phillip Dinh may publish in the future.

Co-authorship network of co-authors of Phillip Dinh

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip Dinh. A scholar is included among the top collaborators of Phillip Dinh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip Dinh. Phillip Dinh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Modi, Nishit B., et al.. (2025). Multiple‐Dose Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Subcutaneous Rusfertide, a Hepcidin Mimetic, in Healthy Subjects. Clinical Pharmacology in Drug Development. 14(4). 311–323. 1 indexed citations

Olander, Kenneth W., Gary Jerkins, Fenghe Lu, et al.. (2020). A randomized Phase 2 trial assessing the safety and efficacy of omidenepag isopropyl 0.002% once and twice daily in subjects with primary open-angle glaucoma or ocular hypertension (Spectrum 6). Investigative Ophthalmology & Visual Science. 61(7). 4258–4258. 1 indexed citations

Modi, Nishit B., et al.. (2019). Pharmacodynamics, Efficacy, and Safety of IPX203 in Parkinson Disease Patients With Motor Fluctuations. Clinical Neuropharmacology. 42(5). 149–156. 16 indexed citations

Tamayo, Aracely, Samir R. Shah, Shobna Bhatia, et al.. (2016). Correlates of disease-specific knowledge among patients with chronic hepatitis B or hepatitis C infection in India. Hepatology International. 10(6). 988–995. 3 indexed citations

Kadayıfçı, Abdurrahman, George Papatheodoridis, MF Yuen, et al.. (2015). Characterization of HBsAg decline in the Tenofovir disoproxil fumarate (TDF) and peginterferon alfa 2A (PEG) combination study for chronic hepatitis B (CHB). Hepatology International. 1 indexed citations

Kim, W. Ray, Thomas Berg, Tarik Asselah, et al.. (2015). Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients. Journal of Hepatology. 64(4). 773–780. 217 indexed citations

Tran, Tram T., Stuart C. Gordon, Scott Fung, et al.. (2015). Hepatitis B e Antigen Status and Hepatitis B DNA Levels in Women of Childbearing Age with Chronic Hepatitis B Infection Screening for Clinical Trials. PLoS ONE. 10(3). e0121632–e0121632. 15 indexed citations

Chan, Henry Lik‐Yuen, Magdy Elkhashab, Huy N. Trinh, et al.. (2015). Association of baseline vitamin D levels with clinical parameters and treatment outcomes in chronic hepatitis B. Journal of Hepatology. 63(5). 1086–1092. 51 indexed citations

Buti, Marı́a, Scott Fung, Edward Gane, et al.. (2015). Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years. Hepatology International. 9(2). 243–250. 46 indexed citations

10.

Dinh, Phillip. (2015). Statistical Challenges in the Analyses of Bone Mineral Density in Pediatric Populations. Therapeutic Innovation & Regulatory Science. 49(4). 569–575. 1 indexed citations

11.

Fung, Scott, Stuart C. Gordon, Zahary Krastev, et al.. (2014). Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log₁₀ copies/ml). Liver International. 35(2). 422–428. 4 indexed citations

12.

Charuworn, Prista, Paul N. Hengen, Raul Aguilar Schall, et al.. (2014). Baseline interpatient hepatitis B viral diversity differentiates HBsAg outcomes in patients treated with tenofovir disoproxil fumarate. Journal of Hepatology. 62(5). 1033–1039. 8 indexed citations

13.

Marcellin, Patrick, Marı́a Buti, Robert A. de Man, et al.. (2014). Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate. Journal of Hepatology. 61(6). 1228–1237. 80 indexed citations

14.

Liu, Yang, Scott Fung, Edward Gane, et al.. (2014). Evaluation of HBV DNA decay kinetics in patients containing both rtM204V/I mutant and wild-type HBV subpopulations during tenofovir DF (TDF) monotherapy or combination therapy with emtricitabine (FTC)/TDF. Journal of Medical Virology. 86(9). 1473–1481. 8 indexed citations

15.

Gordon, Stuart C., Zahary Krastev, Andrzej Horban, et al.. (2013). Efficacy of Tenofovir Disoproxil Fumarate At 240 Weeks in Patients With Chronic Hepatitis B With High Baseline Viral Load. Hepatology. 58(2). 505–513. 86 indexed citations

16.

Berg, Thomas, Fabien Zoulim, Bernd Moeller, et al.. (2013). Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients. Journal of Hepatology. 60(4). 715–722. 60 indexed citations

17.

Teperman, Lewis, Fred Poordad, Natalie Bzowej, et al.. (2013). Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation. Liver Transplantation. 19(6). 594–601. 69 indexed citations

18.

Fung, Scott, Peter Kwan, Milotka Fabri, et al.. (2013). Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B. Gastroenterology. 146(4). 980–988.e1. 114 indexed citations

19.

Dinh, Phillip & Xiao‐Hua Zhou. (2006). Nonparametric Statistical Methods for Cost‐Effectiveness Analyses. Biometrics. 62(2). 576–588. 21 indexed citations

20.

Melvin, Ann J., et al.. (2004). Rapid HIV Type 1 Testing of Women Presenting in Late Pregnancy with Unknown HIV Status in Lima, Perú. AIDS Research and Human Retroviruses. 20(10). 1046–1052. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact